(Q44637676)

English

Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella

scientific article published on 9 July 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Salmonella enterica

0 references

0 references

author name string

Zhongpeng Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Min Li

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Deyan Luo

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Li Xing

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shuo Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yueqiang Duan

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Penghui Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Xiliang Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

9 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5214-5219

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Rough vaccines in animal brucellosis: structural and genetic basis and present status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

The "effects" of Rev-1 vaccination of sheep and goats on human brucellosis in Greece

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Brucella spp. lumazine synthase: a novel antigen delivery system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Vectors for enhanced gene expression and protein purification in Salmonella.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Entry route of Salmonella typhimurium directs the type of induced immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Epidemiology and control of brucellosis in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Construction of attenuated Salmonella typhimurium Strain expressing Helicobacter pylori conservative region of adhesin antigen and its immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

T cell immunity to brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.075

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.06.075

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44637676&oldid=2030456332"